Today The OLD National Bancorp IN Sells 209,529 Shares of MetLife, Inc. (MET)

Today The OLD National Bancorp IN Sells 209,529 Shares of MetLife, Inc. (MET)

OLD National Bancorp IN decreased its stake in MetLife, Inc. (NYSE:MET) by 73.0% during the third quarter, according to its most recent filing with the SEC. The institutional investor owned 77,498 shares of the company’s stock after selling 209,529 shares during the period. OLD National Bancorp IN’s holdings in MetLife were worth $3,443,000 as of its most recent SEC filing.

A number of other large investors also recently modified their holdings of MET. Nisa Investment Advisors LLC boosted its stake in shares of MetLife by 9.0% in the second quarter. Nisa Investment Advisors LLC now owns 331,350 shares of the company’s stock valued at $13,199,000 after buying an additional 27,446 shares during the last quarter. LS Investment Advisors LLC boosted its stake in shares of MetLife by 5.4% in the second quarter. LS Investment Advisors LLC now owns 33,490 shares of the company’s stock valued at $1,334,000 after buying an additional 1,723 shares during the last quarter. Robeco Institutional Asset Management B.V. boosted its stake in shares of MetLife by 36.8% in the second quarter. Robeco Institutional Asset Management B.V. now owns 358,295 shares of the company’s stock valued at $14,270,000 after buying an additional 96,479 shares during the last quarter. PGGM Investments boosted its stake in shares of MetLife by 5.7% in the second quarter. PGGM Investments now owns 634,775 shares of the company’s stock valued at $25,283,000 after buying an additional 34,194 shares during the last quarter. Finally, Aviance Capital Management LLC bought a new stake in shares of MetLife during the second quarter valued at $274,000. 75.21% of the stock is currently owned by institutional investors.

Shares of MetLife, Inc. (NYSE:MET) opened at 54.91 on Wednesday. MetLife, Inc. has a one year low of $35.00 and a one year high of $58.09. The stock’s 50 day moving average price is $54.80 and its 200 day moving average price is $47.89. The stock has a market cap of $60.35 billion, a price-to-earnings ratio of 16.87 and a beta of 1.69.

MetLife (NYSE:MET) last posted its earnings results on Wednesday, November 2nd. The company reported $1.28 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $1.24 by $0.04. MetLife had a net margin of 5.58% and a return on equity of 6.99%. The firm earned $17.70 billion during the quarter, compared to the consensus estimate of $17.03 billion. During the same quarter last year, the firm earned $0.62 EPS. The firm’s revenue for the quarter was down 99.9% on a year-over-year basis. Analysts forecast that MetLife, Inc. will post $4.65 earnings per share for the current year.

The business also recently announced a quarterly dividend, which will be paid on Monday, March 13th. Investors of record on Monday, February 6th will be issued a $0.40 dividend. The ex-dividend date is Thursday, February 2nd. This represents a $1.60 annualized dividend and a yield of 2.91%. MetLife’s dividend payout ratio (DPR) is presently 49.23%.

MET has been the topic of several analyst reports. Credit Suisse Group initiated coverage on MetLife in a research note on Friday, October 7th. They set a “neutral” rating and a $51.00 price objective on the stock. Argus set a $54.00 target price on MetLife and gave the company a “buy” rating in a research note on Friday, October 7th. Bank of America Corporation set a $51.00 target price on MetLife and gave the company a “buy” rating in a research note on Thursday, October 6th. Deutsche Bank AG reaffirmed a “hold” rating and set a $44.00 target price on shares of MetLife in a research note on Saturday, October 8th. Finally, Zacks Investment Research raised MetLife from a “sell” rating to a “hold” rating in a research note on Monday, October 17th. One analyst has rated the stock with a sell rating, four have given a hold rating, eleven have given a buy rating and one has issued a strong buy rating to the company. MetLife presently has a consensus rating of “Buy” and a consensus target price of $53.31.

In other MetLife news, EVP Frans Hijkoop sold 56,250 shares of the business’s stock in a transaction on Wednesday, November 9th. The shares were sold at an average price of $51.48, for a total value of $2,895,750.00. Following the completion of the transaction, the executive vice president now owns 111,813 shares in the company, valued at $5,756,133.24. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, EVP Peter M. Carlson sold 23,636 shares of the business’s stock in a transaction on Friday, December 23rd. The stock was sold at an average price of $54.32, for a total transaction of $1,283,907.52. Following the completion of the transaction, the executive vice president now owns 39,914 shares of the company’s stock, valued at approximately $2,168,128.48. The disclosure for this sale can be found here. Insiders sold a total of 97,083 shares of company stock valued at $5,126,315 in the last quarter. 0.27% of the stock is owned by insiders.

About MetLife

MetLife, Inc (MetLife) is a provider of life insurance, annuities, employee benefits and asset management. The Company’s segments include Retail; Group, Voluntary & Worksite Benefits; Corporate Benefit Funding; Latin America (collectively, the Americas); Asia, and Europe, the Middle East and Africa (EMEA).

Want to see what other hedge funds are holding MET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for MetLife, Inc. (NYSE:MET).

Related posts

Leave a Comment